Core Course

Netherlands (Spring)

Rotterdam
Rotterdam

About this tour

This week-long Study Tour is designed to expose you to new focuses seen worldwide in precision medicine.

While the group will be based in Rotterdam, there will be the opportunity to travel across the country and learn about the topic at hospitals, medical centers, and universities, where tailored treatment options are being developed and better diagnostics tools and techniques are the focus. The Netherlands is also an attractive country for conducting clinical trials, as they can be conducted faster and are more cost-efficient than in most other parts of the world. Therefore, there is also the possibility of learning about the latest developments with regards to treatment options.

Throughout the tour, relevant cultural visits and social events will help you learn about the Dutch culture and better get to know your classmates and instructor(s).

Learning outcomes

  • Observe how new initiatives can come into play and have an impact on the overall patient treatment approach
  • Broaden your knowledge on the type of information needed to establish new methods of disease prevention and treatment
  • Compare and contrast Sweden, the United States, and the Netherlands in their approaches to precision medicine and how it can impact healthcare and medical treatments

Possible activities

  • Visit Erasmus University Rotterdam to learn about tailored care
  • Meet the Mathijssen research group, focusing on translational pharmacology to study the pharmacology of drugs involved in anti-cancer treatment
  • Hear from the Martens research group, focusing on translational cancer genomics and proteomics to establish prognostic and predictive markers according to molecular traits of tumor cells
  • Visit Leiden University Medical Center to learn about their findings on regenerative medicine of tissues and organs
  • Visit Amsterdam University Medical Center Genome Diagnostics, the European reference center for genetic testing of Familial Hypercholesterolemia, imprinting disorders, and cardiogenetics